Considering the high expression of DNMT3A, TET1, DNMT3B, TET3, UHRF2, DNMT1, UHRF1and TDG in Subtype B, changing the tumor microenvironment cell infiltration characteristics by reversing expression of these DNA methylation regulators may be more clinically practical. This evidence concerns the gene DNMT1 and neoplasm.